MB
Mustang Bio, Inc.
MBIO · NASDAQ
$0.52 +4.02% (+$0.02)
1M -2.10%
Market Cap $3.71M
P/E Ratio -
Div. Yield -
ROE 34.23%
Bulios Fair Price
$0.76
46.1% upside
Current Price
$0.52
Undervalued Fair Value Overvalued
According to Bulios Fair Price, MBIO is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
1/9Valuation
100 /100
Cheap P/B 0.49x
P/E N/A
EV/FFO N/A
Growth
0 /100
Declining Book val. growth 40.95%
EPS growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
0 /100
Poor ROIC 45.77%
Asset turnover 0.00x
ROE 34.23%
Debt
100 /100
Low Debt/Equity 0.00x
Current ratio 1.97x
Int. coverage N/A
Stability
39 /100
Moderate Beta 2.05x
Profitable years 0
EPS volatility 19.71%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about MBIO
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Manuel Litchman
Employees
4
Headquarters
Waltham
Upcoming events
18 NOV
Earnings
Upcoming earnings report